CRESCENT BIOPHARMA, INC. - CBIO

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 21
Latest filed: Feb 26, 2026
Form Count
4 11
8-K 3
SCHEDULE 13G 3
SCHEDULE 13G/A 3
SCHEDULE 13D/A 1

Latest files

Filed Form Report period Accession SEC
Feb 26, 2026 8-K Feb 26, 2026 0001628280-26-011988 View
Feb 17, 2026 SCHEDULE 13G 0000902664-26-001077 View
Feb 17, 2026 SCHEDULE 13G/A 0001738048-26-000018 View
Feb 05, 2026 SCHEDULE 13G/A 0000315066-26-000413 View
Dec 17, 2025 4 Dec 15, 2025 0001628280-25-057669 View
Dec 17, 2025 4 Dec 15, 2025 0001628280-25-057671 View
Dec 17, 2025 4 Dec 15, 2025 0001628280-25-057673 View
Dec 17, 2025 4 Dec 15, 2025 0001628280-25-057678 View
Dec 17, 2025 4 Dec 15, 2025 0001628280-25-057681 View
Dec 17, 2025 4 Dec 15, 2025 0001628280-25-057683 View
Dec 17, 2025 4 Dec 15, 2025 0001628280-25-057685 View
Dec 17, 2025 4 Dec 15, 2025 0001628280-25-057687 View
Dec 11, 2025 SCHEDULE 13G 0001193125-25-315863 View
Dec 10, 2025 4 Dec 08, 2025 0001628280-25-056331 View
Dec 10, 2025 4 Dec 08, 2025 0001628280-25-056333 View
Dec 08, 2025 SCHEDULE 13D/A 0001104659-25-119323 View
Dec 08, 2025 4 Dec 04, 2025 0001104659-25-119320 View
Dec 04, 2025 8-K Dec 02, 2025 0001628280-25-055221 View
Nov 06, 2025 8-K Nov 06, 2025 0001628280-25-049865 View
Oct 14, 2025 SCHEDULE 13G/A 0001214659-25-014932 View
Oct 09, 2025 SCHEDULE 13G 0001214659-25-014813 View